Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 67,167 shares at $39.88 ($2.7M) on 2015-09-15, disclosed to the SEC on 2015-09-17.
Scheduled sale ($2.7M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.88 | 10,000 | $399K | 14.8% |
| 2 | $39.88 | 50,000 | $2.0M | 74.1% |
| 3 | $41.39 | 270 | $11K | 0.4% |
| 4 | $41.39 | 6,897 | $285K | 10.6% |
| Total | $40.04 avg | 67,167 | $2.7M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |